| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |